Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
Biomarker Validation for Genomic Assays
Assay Developers Put Their Tests to the Test and Demonstrate the Clinical Utility of Genomic Biomarkers
For full access to this article login to GEN Select now.
Role of Cell-Based Assays in R&D Grows
The Paradigm of One Gene, One Target, One Drug Is Being Widely Revised
- At Cambridge Healthtech Institute's recent "Intelligent Drug Discovery and Development" conference, presenters talked about the ever-evolving role of the cell-based assay in drug development. "In the past, the drug discovery model was pretty straightforward: one gene, one target, one drug. This model has failed," said D. Lansing Taylor, CEO ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.